Carmine Ferrara
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Pharmacology top 10%
- Cancer Research
- Co-authors
- Cesare GridelliAntônio RossiPaolo MaioneCiro GuerrieroDario NicolellaGiuseppe ColantuoniFilomena Del GaizoNasser K. Altorki
- Topics
- Lung Cancer Treatments and Mutations (15 papers)Lung Cancer Research Studies (4 papers)Lung Cancer Diagnosis and Treatment (4 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Carmine Ferrara
27 papers receiving 608 citations
Peers
Comparison fields: 5 of 103
- Oncology 271
- Pulmonary and Respiratory Medicine 234
- Molecular Biology 198
- Pharmacology 144
- Cancer Research 93
Countries citing papers authored by Carmine Ferrara
This map shows the geographic impact of Carmine Ferrara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmine Ferrara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmine Ferrara more than expected).
Fields of papers citing papers by Carmine Ferrara
This network shows the impact of papers produced by Carmine Ferrara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmine Ferrara. The network helps show where Carmine Ferrara may publish in the future.
Co-authorship network of co-authors of Carmine Ferrara
This figure shows the co-authorship network connecting the top 25 collaborators of Carmine Ferrara. A scholar is included among the top collaborators of Carmine Ferrara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmine Ferrara. Carmine Ferrara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 20 | |
| 5 | 62 | |
| 6 | 1 | |
| 7 | 22 | |
| 8 | 24 | |
| 9 | 21 | |
| 10 | 9 | |
| 11 | 1 | |
| 12 | 16 | |
| 13 | 3 | |
| 14 | 24 | |
| 15 | 16 | |
| 16 | 23 | |
| 17 | 1 | |
| 18 | 9 | |
| 19 | 2 | |
| 20 | Effects of alpha-adrenergic agonists on Toxoplasma gondii replication in human umbilical vein endothelial cells. | 7 |
About Carmine Ferrara
Carmine Ferrara is a scholar working on Pulmonary and Respiratory Medicine, Computer Science Applications and Oncology, having authored 28 papers that have together received 631 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (271 citations), Pharmacology (144 citations) and Pulmonary and Respiratory Medicine (234 citations). Carmine Ferrara has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Cesare Gridelli, Antônio Rossi, Paolo Maione, Ciro Guerriero, Dario Nicolella, Giuseppe Colantuoni, Filomena Del Gaizo, Nasser K. Altorki, David F. Yankelevitz and Mark Pasmantier. Their work appears in journals such as Journal of Clinical Oncology, Free Radical Biology and Medicine and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.